The GDP in the Europe region recorded a growth rate of 2.1 percent in 2017 up from 1.8 percent in 2016 which was the highest growth rate recorded since 2007.
In Q4 2021, U.S. current-acco… Read More
The global rare neurodegenerative disease treatment market is projected to witness steady growth at a CAGR of 5%, reaching a valuation of over US$ 116 billion by [read full press r… Read More
New York, United States, 2022-Jun-15 — /EPR Network/ — The Rare Disease Treatment Market is expected to grow at a stupendous rate in the next [read full press release...] Read More
While there will be uncertainties, stakeholders can navigate them by factoring in historic and current drivers of change when strategizing for 2020 and beyond. Among [read full press release… Read More
With Xiaflex the only FDA approved product for this disease, Endo dominates the market
The Peyronie’s Disease Treatment Market is dominated by a single player, Endo International plc w… Read More